Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue.
Iozzo
Patricia
P
Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy. patricia.iozzo@ifc.cnr.it
D054392:Adipokines / Q000502:physiology; D000273:Adipose Tissue / Q000503:physiopathology*; D063385:Cannabinoid Receptor Modulators / Q000502:physiology; D032921:Consensus; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D005227:Fatty Acids / Q000378:metabolism / Q000494:pharmacology; D005938:Glucocorticoids / Q000502:physiology; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D007333:Insulin Resistance / Q000502:physiology*; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D009765:Obesity / Q000503:physiopathology
D054392:Adipokines; D063385:Cannabinoid Receptor Modulators; D005227:Fatty Acids; D005938:Glucocorticoids